4.3 Article

Three men in a boat: The comparison of the combination therapy of botulinum toxin and greater occipital nerve block with bupivacaine, with botulinum toxin monotherapy in the management of chronic migraine

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Treatment of occipital neuralgia using onabotulinum toxin A

Isabela Maria Garcia Marcolla et al.

Summary: The study found that onabotulinum toxin type A is a safe and effective treatment for patients with refractory greater occipital nerve neuralgia, significantly reducing pain severity and frequency without any noticeable side effects.

ACTA NEUROLOGICA SCANDINAVICA (2022)

Article Clinical Neurology

Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial

Debashish Chowdhury et al.

Summary: This study compared the efficacy and tolerability of combination treatment with topiramate and greater occipital nerve block to topiramate monotherapy in adult chronic migraine patients. The results showed that combination treatment was more effective in reducing monthly migraine days and was well tolerated compared to monotherapy.

CEPHALALGIA (2022)

Article Clinical Neurology

A comparison of the clinical efficacy of GON block at the C2 level and GON block at the classical distal occipital level in the treatment of migraine

Mustafa Karaoglan et al.

Summary: This retrospective study compared the efficacy and complications of ultrasound-guided block (C2GON) and distal occiput level block (DOGON) in migraine patients. The results showed that both blocks were effective in treating migraine.

CLINICAL NEUROLOGY AND NEUROSURGERY (2022)

Review Clinical Neurology

Narrative review of peripheral nerve blocks for the management of headache

Jennifer Stern et al.

Summary: Peripheral nerve blocks, especially occipital nerve blocks, are effective treatment options for adults with migraine and other headache disorders, with studies showing reductions in headache frequency, intensity, and/or duration. Overall, they are well tolerated with rare serious side effects reported.

HEADACHE (2022)

Review Clinical Neurology

The processes underlying chronic migraine pathophysiology and its treatment with botulinum toxin type A

Dominic Atraszkiewicz

Summary: Migraine is a complex condition with multiple potential mechanisms, and the pathophysiology of its chronification remains unclear. Botulinum toxin A acts on chronic migraine through various mechanisms.

NEUROLOGY AND CLINICAL NEUROSCIENCE (2021)

Review Clinical Neurology

Current and emerging evidence-based treatment options in chronic migraine: a narrative review

Elio Clemente Agostoni et al.

JOURNAL OF HEADACHE AND PAIN (2019)

Article Clinical Neurology

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

Andrew M. Blumenfeld et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Article Clinical Neurology

The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study

H. L. Gul et al.

ACTA NEUROLOGICA SCANDINAVICA (2017)

Review Clinical Neurology

Treatment of medication-overuse headache: A systematic review

Chia-Chun Chiang et al.

CEPHALALGIA (2016)

Article Clinical Neurology

Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial

K.-L. Lai et al.

ACTA NEUROLOGICA SCANDINAVICA (2016)

Review Clinical Neurology

Managing Migraine During Pregnancy and Lactation

Rebecca Erwin Wells et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)

Review Clinical Neurology

Chronic migraine: risk factors, mechanisms and treatment

Arne May et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Clinical Neurology

Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine

P. Barbanti et al.

NEUROLOGICAL SCIENCES (2015)

Article Clinical Neurology

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

John F. Rothrock et al.

HEADACHE (2014)

Article Clinical Neurology

The cost effectiveness of Botox in Italian patients with chronic migraine

M. Ruggeri

NEUROLOGICAL SCIENCES (2014)

Article Medicine, General & Internal

The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK

Anthony J. Batty et al.

JOURNAL OF MEDICAL ECONOMICS (2013)

Article Clinical Neurology

From poison to remedy: the chequered history of botulinum toxin

F. J. Erbguth

JOURNAL OF NEURAL TRANSMISSION (2008)

Article Pharmacology & Pharmacy

Combination therapy in epilepsy - When and what to use

Patrick Kwan et al.

Article Clinical Neurology

Greater occipital nerve block is ineffective in chronic tension type headache

E Leinisch-Dahlke et al.

CEPHALALGIA (2005)

Article Otorhinolaryngology

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study

WJ Binder et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2000)